{"id":"https://openalex.org/W3207760722","doi":null,"title":"[A Case of Immune-Related Adverse Events Affecting the Lungs, Skin, and Pituitary Gland during Pembrolizumab Treatment].","display_name":"[A Case of Immune-Related Adverse Events Affecting the Lungs, Skin, and Pituitary Gland during Pembrolizumab Treatment].","publication_year":2021,"publication_date":"2021-10-01","ids":{"openalex":"https://openalex.org/W3207760722","mag":"3207760722","pmid":"https://pubmed.ncbi.nlm.nih.gov/34657060"},"language":"ja","primary_location":{"id":"pmid:34657060","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34657060","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Gan to kagaku ryoho. Cancer & chemotherapy","raw_type":"Case Reports"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5016165248","display_name":"Ryota Ito","orcid":"https://orcid.org/0000-0003-0793-5442","observed_orcids":["https://orcid.org/0000-0003-0793-5442"]},"institutions":[{"id":"https://openalex.org/I4405254997","display_name":"Nishiwaki Municipal Hospital","ror":"https://ror.org/02g5mge27","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4405254997"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Ryota Ito","raw_affiliation_strings":["Dept. of Internal Medicine, Nishiwaki Municipal Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dept. of Internal Medicine, Nishiwaki Municipal Hospital","institution_ids":["https://openalex.org/I4405254997"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064724441","display_name":"Hiroki Tatsuoka","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hiroki Tatsuoka","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064642713","display_name":"Tamaki Hirata","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tamaki Hirata","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Sachiko Kimura","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sachiko Kimura","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052559477","display_name":"Youichi Sakamoto","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Youichi Sakamoto","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Takao Kashiwagi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Takao Kashiwagi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031205013","display_name":"Junko Hori","orcid":"https://orcid.org/0000-0002-4248-5742","observed_orcids":["https://orcid.org/0000-0002-4248-5742"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Junko Hori","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057847135","display_name":"Keikichi Miyata","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Keikichi Miyata","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003136392","display_name":"Minoru Kishi","orcid":"https://orcid.org/0009-0001-5585-4519","observed_orcids":["https://orcid.org/0009-0001-5585-4519"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Minoru Kishi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"Masahide Iwai","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Masahide Iwai","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.1997,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.46494991,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":95},"biblio":{"volume":"48","issue":"10","first_page":"1265","last_page":"1267"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/immune-related-adverse-events","display_name":"immune-related adverse events","score":0.8859999775886536},{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/lung-adenocarcinoma","display_name":"lung adenocarcinoma","score":0.9369999766349792},{"id":"https://openalex.org/keywords/interstitial-lung-disease","display_name":"interstitial lung disease","score":0.8659999966621399},{"id":"https://openalex.org/keywords/hypopituitarism","display_name":"hypopituitarism","score":0.9269999861717224},{"id":"https://openalex.org/keywords/drug-induced-rash","display_name":"drug rash","score":0.7950000166893005},{"id":"https://openalex.org/keywords/pd-l1-expression","display_name":"PD-L1 expression","score":0.7409999966621399},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitor-toxicity","display_name":"immune checkpoint inhibitor toxicity","score":0.6579999923706055},{"id":"https://openalex.org/keywords/cortisol","display_name":"cortisol","score":0.7720000147819519}],"concepts":[{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.9674460887908936},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8188654184341431},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6637113094329834},{"id":"https://openalex.org/C2777714996","wikidata":"https://www.wikidata.org/wiki/Q7886","display_name":"Lung","level":2,"score":0.48772892355918884},{"id":"https://openalex.org/C2777914695","wikidata":"https://www.wikidata.org/wiki/Q12192","display_name":"Pneumonia","level":2,"score":0.4519176781177521},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4495960474014282},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.42446231842041016},{"id":"https://openalex.org/C2778491484","wikidata":"https://www.wikidata.org/wiki/Q922411","display_name":"Hypopituitarism","level":2,"score":0.41340941190719604},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.37146681547164917},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3208082318305969},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.1634426712989807},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.1625230312347412}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008168","descriptor_name":"Lung","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010902","descriptor_name":"Pituitary Gland","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:34657060","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34657060","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Gan to kagaku ryoho. Cancer & chemotherapy","raw_type":"Case Reports"},{"id":"mag:3207760722","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34657060","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/case-report","display_name":"Case Report"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3118617714","https://openalex.org/W2970447537","https://openalex.org/W3081520878","https://openalex.org/W2928098985","https://openalex.org/W4415450244","https://openalex.org/W3134313452","https://openalex.org/W4296301868","https://openalex.org/W4415453466","https://openalex.org/W3098006375","https://openalex.org/W6999451914"],"abstract_inverted_index":{"The":[0,24],"patient":[1,25,71,97],"was":[2,22,54,72],"a":[3,64,101],"69-year-old":[4],"man":[5],"diagnosed":[6,56,73,99],"with":[7,12,57,74,100,112],"stage":[8],"\u2163B":[9],"lung":[10],"adenocarcinoma":[11],"95%":[13],"programmed":[14],"death-":[15],"ligand":[16],"1":[17],"expression,":[18],"and":[19,52,69],"pembrolizumab":[20,120],"monotherapy":[21],"initiated.":[23],"exhibited":[26],"fatigue":[27],"from":[28,67],"the":[29,46,70,78,96,106],"12th":[30],"course(36":[31],"weeks":[32,89],"after":[33,63,90],"treatment":[34,91,111],"initiation)":[35],"of":[36,49,80],"treatment.":[37],"Chest":[38],"computed":[39],"tomography":[40],"revealed":[41],"scattered":[42],"ground-glass":[43],"opacities":[44],"in":[45,123],"upper":[47],"lobes":[48],"both":[50,86],"lungs,":[51],"he":[53],"subsequently":[55],"interstitial":[58],"pneumonia.":[59],"Fatigue":[60],"persisted":[61],"even":[62],"drug":[65],"holiday":[66],"pembrolizumab,":[68],"hypopituitarism":[75],"based":[76],"on":[77,85],"results":[79],"endocrinological":[81],"examinations.":[82],"Rashes":[83],"appeared":[84],"legs":[87],"40":[88],"initiation,":[92],"which":[93],"led":[94],"to":[95,119],"being":[98],"drug-induced":[102],"skin":[103],"disorder.":[104],"All":[105],"adverse":[107,116],"events":[108,117],"resolved":[109],"upon":[110],"hydrocortisone.":[113],"Immune-":[114],"related":[115],"due":[118],"may":[121],"occur":[122],"multiple":[124],"organs":[125],"simultaneously.":[126]},"counts_by_year":[{"year":2022,"cited_by_count":2}],"updated_date":"2026-11-02T09:45:03.842371","created_date":"2021-10-25T00:00:00"}